Diplomat Announces 2nd Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Diplomat Pharmacy (DPLO) Misses Q2 EPS by 6c; Lowers EPS Outlook
August 6, 2018 4:26 PM EDTDiplomat Pharmacy (NYSE: DPLO) reported Q2 EPS of $0.17, $0.06 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.42 billion.
GUIDANCE:
Diplomat Pharmacy maintains FY2018 revenue of $5.5-5.9 billion, versus the consensus of $5.67... More
